However, molecular analysis of SRD5A2 gene variants is generally required to confirm the diagnosis, since the hormonal and clinical profiles of 5ARD2 often overlap with other conditions, including androgen insensitivity syndrome, 17 beta-hydroxylase deficiency and defects in the NR5A1 gene. This evidence concerns the gene SRD5A2 and androgen insensitivity syndrome.